Healthcare Industry News: Biovail
News Release - March 16, 2006
Schering-Plough Announces Gregory J. Szpunar Appointed Group Vice President, Global Project Management, Schering-Plough Research InstituteKENILWORTH, N.J., March 16 (HSMN NewsFeed) -- Schering-Plough Corporation (NYSE: SGP ) announced today that Gregory J. Szpunar, R.PH., Ph.D., has been appointed group vice president, Global Project Management, Schering-Plough Research Institute (SPRI).
In this role, Szpunar is responsible for executing and managing a global project management function for Schering-Plough's product development and commercialization process. He is based in Kenilworth and reports to Thomas Koestler, Ph.D., executive vice president, Global Development, SPRI.
Szpunar joined Schering-Plough from Biovail Corporation, where he served as chief scientific officer and senior vice president for R&D and Manufacturing. Prior to that position, he was senior vice president, Product Development, at Pharmacia Corporation.
Szpunar holds a Ph.D. in Pharmaceutics from the University of Michigan, Ann Arbor, and a B.S. in Pharmacy from Wayne State University, in Detroit, Michigan.
Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 32,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.